EI
DAVA icon

EFG International’s Endava DAVA Stock Holding History

EFG International’s Portfolio DAVA Stock Details DAVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$632 – 1059
2025
Q4 		$632 Buy
+100
New +$766 ﹤0.01% 860

Other funds holding DAVA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
CU
CDAM (UK) London, United Kingdom $387M AUM 4.05% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
KA
Kerrisdale Advisers Miami, Florida $399M AUM 42.87% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return

EFG International's DAVA Position: Q1 2026 in Review

EFG International sold out of Endava (DAVA) in Q1 2026, closing a stake of 100 shares — an estimated $632 sold.

EFG International first reported a position in DAVA in Q4 2025 and held it in 1 quarter. The position peaked at $632 in Q4 2025. 80 funds tracked by Wall St. Rank hold DAVA as of Q1 2026.

  • EFG International reported no remaining Endava position as of Q1 2026 after selling out during the quarter.
  • EFG International sold 100 Endava shares in Q1 2026, an estimated $632.
  • EFG International first reported a position in Endava in Q4 2025 and held it in 1 quarter.
  • EFG International's Endava position peaked at $632 in Q4 2025.
  • 80 funds tracked by Wall St. Rank held Endava as of Q1 2026.

Based on EFG International's 13F filing for Q1 2026, filed 15 May 2026.